HCA Healthcare (HCA) beat expectations in FY2026 on revenue of $95.7B versus the $92.1B estimate (+10.9% YoY) and EPS of $2.10. Below is the full HCA Healthcare earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$95.7B (vs $92.1B est · +3.9% surprise · +10.9% YoY)
EPS
$2.10 (vs $1.93 est · +8.8% surprise · +24.2% YoY)
Share price
$317.44 (-3.6%)
Market cap
$1.89T
What you'll find
Next HCA Healthcare (HCA) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment HCA Healthcare reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in HCA Healthcare (HCA)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is HCA Healthcare's next earnings date?
HCA Healthcare's (HCA) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did HCA Healthcare (HCA) beat or miss earnings?
In FY2026, HCA Healthcare (HCA) posted beat results — revenue of $95.7B versus the $92.1B estimate (+3.9% surprise) and EPS of $2.10 versus $1.93 expected (+8.8% surprise). Magnisto decodes every HCA Healthcare (HCA) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for HCA Healthcare (HCA) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for HCA Healthcare (HCA), anchored to the current $317.44 share price, so you can weigh the bull, base and bear cases for HCA Healthcare side by side.
Is HCA Healthcare (HCA) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether HCA Healthcare fits your own thesis and risk profile. This is research, not investment advice.